Aebersold Sarah sold BLFS

January 6, 2025 · Form 4 insider transaction

Aebersold Sarah sold 240 shares of BioLife Solutions, Inc. at $27.02 per share, a transaction worth $6.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Disposed (sell-side)
Shares
240
Price
$27.02
Total value
$6.5K
Role
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 6, 2025
Filing dateJanuary 8, 2025
Shares owned after60,244
OwnershipDirect
10b5-1 planYes
AmendedNo

Footnotes

The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

View the original Form 4 on SEC EDGAR